UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
HKPD holding history
Cellyan Biotechnology Co., Ltd in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HKPD overviewAll 13F holders of HKPDFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,081
- Value
- $411
- % of portfolio
- <0.1%
- Quarters held
- 6
- Since Q1 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,081 | $411 | <0.1% | +971+882.7% | Added | Holders |
| Q1 2026 | 110 | $63 | <0.1% | −1,426−92.8% | Reduced | Holders |
| Q4 2025 | 1,536 | $1.27K | <0.1% | +1,438+1,467.3% | Added | Holders |
| Q3 2025 | 98 | $144 | <0.1% | −20,777−99.5% | Reduced | Holders |
| Q2 2025 | 20,875 | $26.7K | <0.1% | +20,603+7,574.6% | Added | Holders |
| Q1 2025 | 272 | $294 | <0.1% | +272 | New | Holders |